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Abstract. 
 
Type IV collagen is a major component of 
basement membranes. We have characterized 11 muta-
tions in 
 
emb-9
 
, the 
 
a
 
1(IV) collagen gene of 
 
Caenorhab-
ditis elegans
 
, that result in a spectrum of phenotypes. 
Five are substitutions of glycines in the Gly-X-Y do-
main and cause semidominant, temperature-sensitive 
lethality at the twofold stage of embryogenesis. One is a 
glycine substitution that causes recessive, non–temper-
ature-sensitive larval lethality. Three putative null al-
leles, two nonsense mutations and a deletion, all cause 
recessive, non–temperature-sensitive lethality at the 
threefold stage of embryogenesis. The less severe null 
phenotype indicates that glycine substitution contain-
ing mutant chains dominantly interfere with the func-
tion of other molecules. The 
 
emb-9
 
 null mutants do not 
stain with anti–EMB-9 antisera and show intracellular 
accumulation of the 
 
a
 
2(IV) chain, LET-2, indicating 
that LET-2 assembly and/or secretion requires EMB-9. 
Glycine substitutions in either EMB-9 or LET-2 cause 
intracellular accumulation of both chains. The degree 
of intracellular accumulation differs depending on the 
allele and temperature and correlates with the severity 
of the phenotype. Temperature sensitivity appears to 
result from reduced assembly/secretion of type IV col-
lagen, not defective function in the basement mem-
brane. Because the dominant interference of glycine 
substitution mutations is maximal when type IV col-
lagen secretion is totally blocked, this interference ap-
pears to occur intracellularly, rather than in the base-
ment membrane. We suggest that the nature of 
dominant interference caused by mutations in type IV 
collagen is different than that caused by mutations in 
fibrillar collagens.
 
B
 
asement
 
 membranes are specialized sheets of ex-
tracellular matrix that separate groups of cells
from each other and/or from underlying intersti-
tial matrix. Type IV collagen forms a complex branched
network that is a major component of basement mem-
branes (Yurchenco and Schittny, 1990; Kuhn, 1994). We
are using the nematode 
 
Caenorhabditis elegans
 
 as a model
system to study the roles of type IV collagen in basement
membrane function, as well as to examine the assembly of
basement membrane molecules in vivo. Homologues of
several basement membrane proteins, including type IV
collagen, perlecan, nidogen/entactin, laminin, and SPARC,
have been identified in 
 
Caenorhabditis elegans
 
 (Kramer,
1994; Kramer, J., unpublished results). The strong evolu-
tionary conservation of these molecules indicates that
many aspects of basement membrane structure and func-
tion have been conserved between nematodes and mam-
mals.
The predominant form of type IV collagen is a hetero-
trimer containing two 
 
a
 
1(IV) chains and one 
 
a
 
2(IV) chain
(Yurchenco and Schittny, 1990; Kuhn, 1994). The largest
portion of the type IV collagen molecule is the central
Gly-X-Y repeat domain, which folds into a triple-helical
structure. The Gly-X-Y domain contains 
 
z
 
20 interrup-
tions of the Gly-X-Y repeats, which provide flexibility to
the molecule. The amino-terminal 7S domain and the
globular carboxyl-terminal NC1 domain contain several
conserved cysteine residues that participate in intra- and
intermolecular disulfide bonding. Formation of the type
IV collagen network in basement membranes involves
dimerization of NC1 domains and tetramerization of 7S
domains, as well as lateral interactions along the triple-
helical domain.
In mammals, six type IV collagen genes, encoding 
 
a
 
1–
 
a
 
6(IV) chains, have been identified (Hudson, et al., 1993;
Kuhn, 1994). These chains are known to assemble into
(
 
a
 
1)
 
2
 
a
 
2 and (
 
a
 
3)
 
2
 
a
 
4 heterotrimers, but it is not clear how
 
a
 
5 and 
 
a
 
6 chains assemble. While the 
 
a
 
1 and 
 
a
 
2 chains are
present in all basement membranes, the other chains have
restricted tissue distributions, being most abundant in the
kidney (Langeveld et al., 1988; Sanes et al., 1990; Kashtan
and Kim, 1992; Ninomiya et al., 1995).
Two type IV collagen genes have been characterized in
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C. elegans
 
 (Guo and Kramer, 1989; Sibley et al., 1993, 1994)
and sea urchin (Exposito et al., 1993, 1994), and a single
gene in 
 
Drosophila
 
 (Blumberg et al., 1987), 
 
Ascaris
 
 (Pet-
titt and Kingston, 1991), and 
 
Brugia
 
 (Caulagi and Rajan,
1995). In both 
 
C. elegans
 
 and sea urchin, one type IV col-
lagen gene is 
 
a
 
1-like and the other is 
 
a
 
2-like, suggesting
that their products may form (
 
a
 
1)
 
2
 
a
 
2 heterotrimers. No
more than two type IV collagen genes have been identi-
fied in any invertebrate, and there is evidence that only
two type IV collagen genes exist in 
 
C. elegans
 
 (Guo and
Kramer, 1989).
The genetic designations of the 
 
a
 
1(IV)-like and 
 
a
 
2(IV)-
like genes of 
 
C. elegans
 
 are 
 
emb-9
 
 and 
 
let-2
 
, respectively.
Ultrastructural analyses have identified basement mem-
branes covering the pseudocoelomic face of the hypoder-
mis and surrounding the pharynx, intestine, gonad, and
body wall muscles of 
 
C. elegans
 
 (Albertson and Thomson,
1976; White et al., 1976; White, 1988). Using chain-specific
antisera, the EMB-9 and LET-2 chains of 
 
C. elegans
 
 were
found to colocalize and be present in all of these basement
membranes, except those on the pseudocoelomic face of
body wall muscles and the region of the hypodermis be-
tween body wall muscle quadrants (Graham et al., 1997).
Thus, the EMB-9 and LET-2 chains are most similar to the
mammalian 
 
a
 
1 and 
 
a
 
2(IV) chains both structurally and in
having a wide tissue distribution.
Mutations have been identified in the 
 
a
 
3, 
 
a
 
4, and
 
a
 
5(IV) genes of human (Lemmink et al., 1994; Mochizuki
et al., 1994; Antignac 1995; Tryggvason, 1995), the 
 
a
 
5(IV)
gene of dog (Zheng et al., 1994), the 
 
a
 
3(IV) gene of mouse
(Cosgrove et al., 1996; Miner and Sanes, 1996), and the 
 
a
 
1
and 
 
a
 
2(IV) genes of 
 
C. elegans
 
 (Guo and Kramer, 1989;
Sibley et al., 1993, 1994). The mutations in the mammalian
 
a
 
3–
 
a
 
5(IV) genes can cause Alport syndrome, a progres-
sive glomerulonephritis with variably associated eye and
ear defects. The primarily renal focus of Alport syndrome
is consistent with the fact that the 
 
a
 
3–
 
a
 
5 chains are most
abundant in the kidney glomerulus. Antibody staining of
kidney samples from patients with mutations in the 
 
a
 
3, 
 
a
 
4,
or 
 
a
 
5(IV) gene shows that all three chains are absent, sug-
gesting that they are interdependent for normal assembly
and/or deposition into the basement membrane (Peissel et
al., 1995). Mutations have not been identified in the mam-
malian 
 
a
 
1 or 
 
a
 
2(IV) genes.
Mutations have been identified in the 
 
C. elegans emb-9
 
and 
 
let-2
 
 genes, homologues of the mammalian 
 
a
 
1 and
 
a
 
2(IV) genes (Guo et al., 1991; Sibley et al., 1994). Muta-
tions in both genes can cause arrest during embryonic de-
velopment, indicating that there is a requirement for type
IV collagen function in 
 
C. elegans
 
 embryogenesis. The mo-
lecular and phenotypic characteristics of 17 mutations of
 
let-2
 
 have been analyzed (Sibley et al., 1994). 15 of the mu-
tations were found to be substitutions for glycine residues
in the Gly-X-Y domain and to cause a wide range of phe-
notypes. The mildest of these were nearly wild-type at 15
and 20
 
8
 
C but embryonic lethal at 25
 
8
 
C. The most severe al-
lele was embryonic lethal at all temperatures. The most se-
vere phenotype was arrest at the twofold stage of embry-
onic development, but larval arrest and adult sterility were
also seen, particularly at intermediate temperatures. Three
mutations in the 
 
emb-9
 
 gene were identified as glycine to
glutamate substitutions (Guo et al., 1991). These three
mutations result in very similar temperature-sensitive phe-
notypes, with twofold arrest as their most severe effect.
In this study, we have molecularly and genetically char-
acterized 11 
 
emb-9
 
 mutations that produce a range of phe-
notypes. We show that null mutations of 
 
emb-9
 
 cause a
less severe phenotype than most missense mutations. Us-
ing chain-specific antisera, we show that missense muta-
tions in either chain cause intracellular accumulation of
both chains and that the degree of intracellular accumula-
tion is correlated with the severity of the phenotype. In
 
emb-9
 
 null mutants, the LET-2 chain is shown to accumu-
late intracellularly and not be secreted.
 
Materials and Methods
 
Nematode Strains
 
C. elegans
 
 strains were maintained and handled as described (Brenner,
1974). The 
 
C. elegans
 
 Bristol strain N2 has been designated as wild type.
Animals homozygous for the 
 
emb-9
 
 alleles 
 
g23
 
, 
 
g34
 
, 
 
b117
 
, 
 
b189
 
, and 
 
hc70
 
(Miwa et al., 1980; Wood et al., 1980; Cassada et al., 1981) were main-
tained at 15
 
8
 
C. The 
 
emb-
 
9 alleles 
 
st540
 
, 
 
st545
 
 (Williams and Waterston,
1994), 
 
cg45
 
, 
 
cg46
 
, 
 
cg56
 
, and 
 
cg57
 
 (see below) were maintained as het-
erozygotes with 
 
qC1
 
, a balancer chromosome that prevents recombination
in the region of 
 
emb-9
 
 (Edgley et al., 1995). The following 
 
let-2
 
 alleles
were used: 
 
g25, g30
 
 (Miwa et al., 1980; Cassada et al., 1981), 
 
b246
 
 (Wood
et al., 1980), 
 
mn109
 
, 
 
mn129
 
, and 
 
mn139
 
 (Meneely and Herman, 1979).
 
Generation of emb-9 Alleles
 
The 
 
emb-9(cg56)
 
 allele was generated using the strain 
 
unc-32(e189)/qC1;
cgEx1[emb-9(
 
1
 
)rol-6(su1006)]
 
. The 
 
unc-32
 
 marker is tightly linked to
 
emb-9
 
 and used to identify chromosome III. 
 
cgEx1
 
 is an extrachromo-
somal array carrying the wild-type 
 
emb-9
 
 gene and 
 
rol-6(su1006)
 
, which
confers a right roller phenotype (Mello et al., 1991; Kramer and Johnson,
1993). The strain was mutagenized with ethyl methanesulfonate (EMS)
and grown at 15
 
8
 
C. F1 Rol non-Unc animals were isolated onto separate
plates and shifted to 25
 
8
 
C. Plates were screened for the presence of Rol
Unc and the absence of non-Rol Unc F2 progeny. One allele, 
 
cg56
 
, was
isolated and backcrossed twice using the following scheme: The 
 
unc-32
emb-9(cg56)/qC1; cgEx1
 
 animals were crossed with N2 males, and cross
progeny males were individually crossed into 
 
unc-32/qC1
 
 hermaphrodites.
Offspring from this cross that produced approximately one-quarter lethal
and one-quarter 
 
qC1
 
 progeny, indicating they were 
 
unc-32 emb-9(cg56)/
qC1
 
, were selected and maintained.
Putative null mutations were generated using the strain 
 
unc-36(e251)
emb-9(g23); qDp3. qDp3 is a free duplication that carries unc-36(1) and
emb-9(1). The strain does not survive at 258C because of the semidomi-
nance of emb-9(g23). The strain was mutagenized with EMS and grown at
158C for two generations. The F2s were shifted to 258C and animals that
survived were isolated onto separate plates. Three alleles, cg45, cg46, and
cg57, were isolated and backcrossed four times as follows: unc-36 emb-
9(cg45, cg46, or cg57); qDp3 animals were mated with N2 males, and the
resulting males were crossed individually into unc36/qC1 hermaphrodites.
F1 cross progeny that produced approximately one-quarter lethal and
one-quarter qC1 progeny, indicating that they were unc-36 emb-9/qC1,
were selected.
Phenotypic Characterization of emb-9 Alleles
emb-9 mutants were scored for viability at 15, 20, and 258C. Animals het-
erozygous for emb-9 were generated by crossing the mutant strains with
wild-type males. The heterozygotes were placed individually onto sepa-
rate temperature-equilibrated plates. Eggs laid within the next 6–7 h
(258C), 8–10 h (208C), or 14–16 h (158C) were counted, and the parent was
removed. 1 d later, plates were examined to determine the numbers of
eggs that had hatched, or that failed to hatch (Emb). Plates were scored
again after 3–4 d (258C), 5–6 d (208C), or 7–8 d (158C) to determine the
number of animals that had developed to adults (Ad). Animals that were
severely abnormal and sterile as adults were noted (Ste). Larvae not ac-
counted for as adults were considered to have arrested during larval de-Gupta et al. Caenorhabditis elegans Type IV Collagen Mutants 1187
velopment (Acc). The number of Acc animals could be reliably inferred
since the N2, unc-32, and unc-36 controls gave very low percentages of
Acc larvae at all temperatures. The total Emb and Acc for N2, unc-32, and
unc-36 were from 0–3%. These background values have been subtracted
from the results obtained from the relevant emb-9 alleles linked to unc-32
or unc-36. At least 200 embryos were scored for each strain at each tem-
perature.
Complementation Tests
st545 and st540 were previously identified as alleles of emb-9 by testing for
complementation with the emb-9(hc70) allele (Williams and Waterston,
1994). We retested for complementation using the putative null allele
emb-9(g23cg45). unc-36 emb-9(g23cg45)/qC1 hermaphrodites were crossed
with N2 males, and single cross progeny males were mated with st545/qC1
and st540/qC1. The production of one-quarter embryonic lethal progeny
from these crosses indicated failure of st545 or st540 to complement emb-
9(g23cg45).  The presence of viable cross progeny males indicated that the
mating was successful. The absence of qC1 homozygous cross progeny in-
dicated that the male was of the genotype unc-36 emb-9(g23cg45)/1 1.
Identification of Nucleotide Alterations in emb-9 Alleles
Genomic DNAs were prepared from emb-9 mutant strains and the wild-
type N2 strain as previously described (Kramer et al., 1988). g23, g34,
hc70, b117, and b189 carrying strains were grown as homozygotes at 158C,
and  st540,  st545, and cg56 were maintained as heterozygotes balanced
across from qC1. The cg45, cg46, and cg57 alleles were maintained as unc-
36 emb-9; qDp3 strains.
Nucleotide alterations were identified using either the chemical mis-
match method or by directly sequencing the entire emb-9 gene. PCR frag-
ments (1–2 kb) of wild-type and emb-9 mutant DNAs were prepared by
incubating genomic DNA (500–700 ng) with 13 PCR buffer (GIBCO BRL,
Gaithersburg, MD), 2 mM MgCl2 , 2.5 ng/ml BSA, 200 mM dNTPs, and 2.5 U
Taq polymerase (GIBCO BRL) in a total volume of 100 ml. PCR samples
were incubated at 948C for 1 min, 47–638C (depending on Tm of primers)
for 1 min, and 728C for 1 min. This temperature cycle was repeated 30
times in an automated temperature cycler. PCR fragments were generated
so as to overlap one another by 200–300 bp. Six 1–2-kb fragments were
used to span the emb-9 gene, including 484 bp 59 of the start codon and
111 bp 39 of the stop codon. PCR fragments were purified using
Geneclean (Bio 101 Inc., La Jolla, CA). Nucleotide alterations in these
fragments were identified using the chemical mismatch detection proce-
dure (Montandon et al., 1989). Point mutations were identified by direct
sequencing of PCR fragments in the areas of mismatch, using Sequenase
(United States Biochemical Corp., Cleveland, OH) and a modified an-
nealing procedure (Kusukawa et al., 1990).
Several mutations were identified by directly sequencing overlapping
PCR fragments that span the entire emb-9 gene. PCR fragments were
cleaned using Centricon 100 columns (Amicon, Beverly, MA). 200–300 ng
of template DNA was used for Taq DyeDeoxy terminator thermal cycle
sequencing (Appiled Biosystems, Inc., Foster City, CA). Samples were
spun through spin columns (model Centri-Sep; Princeton Separations Inc.,
Adelphia, NJ) and dried in a vacuum centrifuge. Each sample was resus-
pended in 4 ml of formamide-EDTA solution (83% deionized formamide,
8 mM EDTA, pH 8.0). Samples were denatured at 908C for 2 min, trans-
ferred immediately onto ice, and loaded onto a 6% polyacrylamide gel on
an automated sequencer (model 373A; Applied Biosystems, Inc.).
Immunofluorescent Staining of C. elegans Embryos
Animals carrying temperature-sensitive alleles, emb-9(g23, g34, hc70,
b117, b189) and let-2(b246, g25, g30, mn109, mn129, mn139), were main-
tained as homozygotes at 158C. To collect embryos raised at higher tem-
peratures, plates containing a mixed population were shifted from 15 to 20
or 258C and allowed to lay eggs overnight.
Embryos were isolated from animals by alkaline hypochlorite (5:3:1
water/4M NaOH/bleach) treatment for 7–10 min. The eggs were washed
several times with PBS, fixed with 3% paraformaldehyde in PBS for 15
min at room temperature, rinsed with distilled water (dH2O) and then
stored at 2808C in 100% methanol for 30 min to 7 d.
Fixed embryos were rehydrated, treated with 6 M urea, 0.1 M glycine,
pH 3.5, for 15 min at room temperature, rinsed with dH2O, and blocked
for 1 h in PBS containing 0.5% Tween-20 (PBS-T) and 10% normal don-
key serum (NDS)1. Primary antibodies against C. elegans type IV collagen
and myosin heavy chain B were added in PBS-NDS for 1 h at 378C. The
embryos were then washed three times for 15 min each with PBS-T and
incubated for 1 h at 378C with secondary antibodies (Jackson ImmunoRe-
search, West Grove, PA) and 0.1 mg/ml diamidinophenolindole in PBS-
T–NDS, washed 33 for 15–30 min with PBS-T, and then mounted in
DABCO medium (20% glycerol, 10% polyvinyl alcohol, 2.5% DABCO
in 40 mM Tris-HCL, pH 8.3) with phenylenediamine freshly added to 1
mg/ml.
The chain-specific anti–type IV collagen antisera used in this study
have been described (Graham et al., 1997). Affinity-purified antiserum
NW1910 was used to identify the a1(IV) chain EMB-9, and affinity-puri-
fied NW68 antiserum was used to identify the a2(IV) chain LET-2. The
5-8 mouse monoclonal antibody against C. elegans myosin heavy chain
UNC-54 (Miller et al., 1983) was used to stain body wall muscle cells. The
primary antibodies were detected using fluorescein-conjugated donkey
anti–rabbit and/or rhodamine-conjugated donkey anti–mouse IgG sec-
ondary antibodies.
1. Abbreviation used in this paper: NDS, normal donkey serum.
Figure 1. Phenotypes of off-
spring from emb-9/1 moth-
ers. The percentage of prog-
eny derived from emb-9/1
heterozygote mothers that
arrested during embryogene-
sis (Emb), arrested as larvae
(Acc), became sterile adults
(Ste), or hatched as severely
deformed L1s (abn. L1) are
indicated. Each allele was
tested at 158C (left bars),
208C (middle bars), and 258C
(right bars). The 11 emb-9 al-
leles have been divided into
four phenotypic classes (I–
IV) based on their tempera-
ture sensitivity, dominance,
and predominant stage of ar-
rest. Completely recessive
emb-9 alleles would be expected to produce 25% or less abnormal progeny, while semidominant alleles could result in up to 75% abnor-
mal progeny. At least 200 progeny were examined for each allele at each temperature.The Journal of Cell Biology, Volume 137, 1997 1188
Results
Phenotypic Characterization of emb-9 Mutants
Eight alleles of emb-9 were characterized for their effects
at 15, 20, and 258C. Progeny from heterozygous, emb-9/1,
mothers were scored for those that arrested during em-
bryogenesis (Emb) or larval development (Acc), or be-
came sick, sterile adults (Ste) (Fig. 1). For recessive alleles,
25% or fewer animals should show abnormal phenotypes,
while semidominant alleles could result in up to 75% ab-
normal animals. These emb-9 alleles were grouped into
three classes based on their general phenotypic character-
istics.
The class I alleles, b117, g23, hc70, b189, and g34, are all
strongly temperature sensitive. At 158C, there is a very low
level of lethality or sterility. At 208C, there is a large in-
crease in larval lethality in all except the b117 allele. The
vast majority of these larvae arrest at the L1 or L2 stages.
At 258C, there is approximately 25% embryonic lethality
for each of the alleles, indicating that essentially all ho-
mozygous mutant animals arrest as embryos. This result is
consistent with the 100% embryonic lethality seen when
homozygous embryos are shifted to 258C (Cassada et al.,
1981; Kramer, J., unpublished results). Larval lethality and
sick, sterile adults increase the total percentages of abnor-
mal animals to 37 to 48%, indicating that each of these al-
leles is semidominant.
The class II alleles, st545 and st540, show high levels of
embryonic lethality and mild temperature sensitivity. st545
is essentially a recessive, embryonic lethal. It shows z25%
embryonic arrest at all temperatures and a very low level
of larval arrest at 20 and 258C. st540 appears to be mildly
cold sensitive, displaying decreased embryonic lethality at
25 versus 158C and some semidominant larval arrest at the
lower temperature.
The class III allele, cg56, is a recessive, non–tempera-
ture-sensitive larval lethal. All cg56 homozygotes arrest
during the L1–L2 larval stages at all temperatures. There
is no apparent semidominance of this allele.
Generation and Characterization of Putative Null 
Alleles of emb-9
Most emb-9 alleles show semidominant effects, which are
likely to result because mutant protein interferes with the
functions of other molecules. Complete absence of EMB-9
would eliminate any dominant interfering effects and al-
low determination of the phenotype that results when the
a1(IV) collagen chain is missing. For this purpose, a ge-
netic screen was designed to isolate putative null muta-
tions of the emb-9 gene.
Three putative emb-9 null alleles were generated by
screening for mutations that eliminate the temperature-
sensitive dominant lethality of emb-9(g23). A strain carry-
ing two copies of g23 and a wild-type copy of emb-9 on a
duplication, unc-36 emb-9(g23); qDp3[emb-9(1)], is via-
ble and fertile at 158C but dies at 258C. This strain was mu-
tagenized and screened for F2 animals that could survive
and reproduce at 258C, and three putative null alleles,
cg45,  cg46, and cg57, were identified. All three of these al-
leles cause less severe phenotypes than g23. g23 homozy-
gotes grown at 258C arrest at approximately the twofold
length of embryogenesis, when the head and tail of the
elongating embryo have just reached each other (Fig. 2 A).
Arrested embryos show extensive herniations of the body
wall. In contrast, cg45, cg46, and cg57 embryos elongate
further, to at least the threefold stage of embryogenesis
(Fig. 2, B and C). The putative null mutant animals also
display less severe herniations of the body wall.
Phenotypic characterization of the putative null mutations
indicates that they are recessive, embryonic lethals and be-
long to a new phenotypic class, class IV (Fig. 1). Approxi-
mately 25% of the progeny from cg45, cg46, or cg57 het-
erozygous mothers arrest as embryos, at the three- to
fourfold stage. A small number of embryos hatch, but they
are small, herniated, and paralyzed (Fig. 1, abn. L1). These
larvae do not develop further and appear to be homozy-
gous mutant embryos whose egg shells have ruptured. There
is no significant effect of temperature on the phenotype of
these mutants, as would be expected for null mutants.
Figure 2. Differential interference contrast micrographs of emb-9 mutant embryos grown at 258C. (A) emb-9(g23) mutant embryo ar-
rested at the twofold stage of embryogenesis. (B and C) Two focal planes of an emb-9(g23cg46) mutant embryo arrested at the threefold
stage of embryogenesis.Gupta et al. Caenorhabditis elegans Type IV Collagen Mutants 1189
Molecular Identification of emb-9 Mutations
Nine mutations in the emb-9 gene have been identified,
three previously (Guo et al., 1991) and six here, by com-
parison with the wild-type emb-9 gene sequence. The pre-
cise alterations in the mutants are given in Table I and are
shown graphically in Fig. 3. All nine of the mutations are
in the triple-helical (Gly-X-Y) repeat domain of the EMB-9
chain. Six of the mutations result in replacement of glycine
with aspartate, glutamate, or arginine. Two of the putative
null mutations, cg45 and cg57, result in nonsense codons,
and one, cg46, is a deletion of 497 bp. The cg46 deletion
removes the last 22 nucleotides of intron 9 and 475 nucle-
otides of exon 10. Failure to splice this intron would result
in translation termination after incorporation of three
amino acids from intron 9.
Nucleotide alterations were not identified in st545 or
st540 by either chemical mismatch detection or direct se-
quencing of mutant genomic DNAs. These mutations were
previously assigned to emb-9 based on failure to comple-
ment the temperature-sensitive allele emb-9(hc70) (Will-
iams and Waterston, 1994). We retested complementation
of these alleles using the putative null allele cg45 and
found that they do fail to complement (see Materials and
Methods), indicating that they are indeed emb-9 alleles.
Since these alleles are maintained as heterozygotes across
from the qC1 balancer chromosome, the wild-type se-
quence in the background may have interfered with the
detection of these mutant alterations.
Putative Null Mutations of emb-9 Cause Intracellular 
Accumulation of LET-2
We have determined the effects of emb-9 and let-2 muta-
tions on type IV collagen distribution by staining mutant
embryos with chain-specific antisera. The distributions of
EMB-9 and LET-2 in wild-type embryos have been de-
scribed (Graham et al., 1997) and are outlined here for
comparison to the patterns in mutants. Antisera against
EMB-9 and LET-2 show identical staining patterns, sug-
gesting that the two chains assemble into a single hetero-
trimeric collagen molecule. In lima to 1 1/2-fold embryos,
strong type IV collagen stain is seen within body wall mus-
cle cells (Fig. 4, A and B). Beginning in the comma stage,
secreted type IV collagen accumulates beneath the body
wall muscles and around the forming pharynx and intes-
tine. From the twofold stage on, most type IV collagen
stain is extracellular. Both EMB-9 and LET-2 are detected
in the region of the hypodermal basement membrane un-
derlying the body wall muscle quadrants and in the base-
ment membranes surrounding the pharynx, intestine, and
gonad (Fig. 4, C–F). No type IV collagen is detected in the
hypodermal basement membrane between the body wall
muscle quadrants or on the pseudocoelomic face of the
muscles. This pattern is altered by mutations in emb-9 or
let-2.
All three putative emb-9 null mutations have the same
effect on type IV collagen localization. Null mutant em-
bryos do not show any detectable staining with EMB-9–
specific antisera (Fig. 5, A and B). They do stain with LET-2–
specific antisera (Fig. 5, C and D); however, all of the stain
is intracellular, and no LET-2 is detectable in basement
membranes. The intracellular staining pattern is punctate
and frequently appears as two strong spots located on op-
posite sides of each of the body wall muscle cell nuclei. No
LET-2 is detectable within hypodermal, intestinal, or pha-
ryngeal cells. This is consistent with previous evidence that
type IV collagen gene expression occurs in body wall mus-
cle cells but is undetectable in hypodermal, intestinal, and
pharyngeal cells (Graham et al., 1997). The intracellular
accumulation of LET-2 in putative emb-9 null mutants in-
dicates that LET-2, the a2(IV) chain, is not secreted in the
absence of full-length EMB-9, the a1(IV) chain.
Glycine Substitution Mutations Cause Intracellular 
Accumulation of Both Type IV Collagen Chains
Most emb-9 (6 of 11) and let-2 (15 of 17) mutations are
substitutions for glycine residues in the Gly-X-Y repeat
domain of the collagen. We stained the five emb-9 and
twelve let-2 temperature-sensitive glycine substitution mu-
tants with anti–EMB-9 and anti–LET-2 antisera. In all cases,
both antisera gave very similar patterns, indicating that
EMB-9 and LET-2 chains are colocalized in these emb-9
and let-2 mutants. The primary effect seen was loss of type
IV stain from basement membranes and the appearance of
strong intracellular stain in body wall muscle cells. The de-
gree of this effect varied depending on the temperature
and allele and correlated with the severity of the pheno-
type. In the most severe allele/temperature combinations,
Table I. Molecular Identification of emb-9 Mutations
Allele Site of mutation* Amino acid substitution
b189 G 1727 A Gly 213 Glu
cg56 G 2266 A Gly 359 Arg
g34 G 2396 A Gly 402 Glu
g23 G 2414 A Gly 408 Glu
hc70 G 2414 A Gly 408 Glu
cg46 D4592–5089
cg57 C 4953 T Gln 1156 Stop
b117 G 5002 A Gly 1175 Asp
cg45 C 5649 T Gln 1388 Stop
*Numbering in nucleotides with start of translation designated as 11. (Guo et al.,
1991; These sequence data are available from GenBank/EMBL/DDBJ under acces-
sion number X56979.)
Figure 3. Location of the mutations in the C. elegans a1(IV) col-
lagen gene emb-9. The structure of the a1(IV) collagen chain
EMB-9 is shown. The central Gly-X-Y repeat domain is indicated
as an open box, with interruptions of the Gly-X-Y repeats shown
as vertical bars. The amino- and carboxyl-terminal non–Gly-X-Y
domains are shaded. The locations and alterations caused by the
mutations are shown above the structure. The extents of the cg46
deletion mutation are shown by a bar below the structure. The Journal of Cell Biology, Volume 137, 1997 1190
all type IV collagen was intracellular, while milder combi-
nations showed progressively less intracellular stain and
more basement membrane stain.
The emb-9(g23) mutant is shown as an example of the
pattern seen in the five emb-9 mutants (Fig. 6). At 258C,
essentially all type IV collagen stain is found as bright
spots within body wall muscle cells (Fig. 6, A and B). There
is little or no detectable extracellular staining in basement
membranes. At 208C, strong intracellular stain is still seen,
but weak extracellular stain in basement membranes can
be seen as well (Fig. 6, C and D). At 158C, the intensity of
the intracellular stain decreases markedly, and strong ex-
tracellular stain of basement membranes is seen (Fig. 6, E
and F). Note that at 158C, g23 mutants develop normally,
at 208C most hatch but arrest as early larvae, while at 258C
they arrest at the twofold stage of embryogenesis (Fig. 1).
The let-2(b246) mutation causes a milder temperature-
sensitive phenotype than emb-9(g23). At 158C, b246 homo-
zygotes develop normally, at 208C 78% complete develop-
ment to adult, while at 258C they all arrest at the twofold
stage of embryogenesis (Sibley et al., 1994). The milder
phenotype of b246 is reflected in the distribution of type
IV collagen at different temperatures. At 258C, type IV
collagen accumulates intracellularly, and little or no base-
ment membrane stain is detectable (Fig. 7 A). At 208C,
type IV collagen distribution is nearly normal with only a
small amount of intracellular accumulation (Fig. 7 B). At
158C, the type IV collagen distribution is wild-type in ap-
pearance (Fig. 7 C).
Six temperature-sensitive glycine substitution mutants
of  let-2 were analyzed by staining embryos raised at 15, 20,
and 258C with LET-2 antiserum. The percentages of em-
bryos that showed strong intracellular stain in body wall
muscle cells and that showed strong pharyngeal basement
membrane stain were determined (Table II). In general,
intracellular body wall muscle stain increased and pharyn-
geal basement membrane stain decreased with increasing
temperature. Thus, as the temperature increases, secretion
of mutant type IV collagen is more strongly inhibited.
These results indicate that temperature-sensitive glycine
substitution mutations in either EMB-9 or LET-2 cause
both chains to be retained intracellularly. The degree of
intracellular retention and the severity of the phenotype
increase with increasing temperature.
Figure 4. Staining of wild-type
C. elegans embryos with col-
lagen IV antibodies. (A, C, and
E) Embryos stained with type
IV collagen–specific antisera.
(B, D, and F) The same em-
bryos stained with the body
wall muscle myosin antibody.
(A) A 1 1/2-fold embryo
stained with the LET-2–spe-
cific antiserum. The stain is in
body wall muscle cells (m) and
is primarily intracellular at this
stage. (C) A threefold stage
embryo stained with the EMB-
9–specific antiserum. Staining
is seen beneath body wall mus-
cles (m), surrounding the phar-
ynx (p), and on the surface of
the intestine (i). (E) A four-
fold stage embryo stained with
the LET-2–specific antiserum.
The focal plane is near the cen-
ter of the embryo, so the body
wall muscles are not in focus.
Staining of the basement mem-
branes around the pharynx (p)
and intestine (i) are indicated.Gupta et al. Caenorhabditis elegans Type IV Collagen Mutants 1191
A Non–temperature-sensitive Glycine
Substitution Mutation
emb-9(cg56) is a glycine substitution mutation that results
in a non–temperature-sensitive, recessive larval lethal phe-
notype (Fig. 1). Staining of this mutant with either EMB-9
or LET-2 antisera shows the same pattern at all tempera-
tures (Fig. 8). Both EMB-9 and LET-2 show strong accu-
mulation in body wall muscle cells, but there is also very
weak staining of the basement membranes underlying the
body wall muscles. The small amount of extracellular stain-
ing in cg56 mutants is similar to what is seen in emb-9(g23)
mutants grown at 208C and is consistent with the fact that
cg56 animals survive to the L1 stage, as do g23 animals at
208C. The small amount of type IV collagen present in the
basement membranes of cg56 mutant animals is sufficient
to allow completion of embryogenesis.
Class II Mutants of emb-9
In both of the class II mutants, st545 and st540, EMB-9 and
LET-2 chains accumulate intracellularly in body wall mus-
cle cells, and there is no detectable extracellular basement
membrane stain. However, the pattern of intracellular ac-
cumulation in st545 and st540 is different from that in the
other emb-9 and let-2 mutants. The stain in st545 and st540
mutants generally appears as a ring surrounding the nu-
cleus (Fig. 9 A), while in all other emb-9 and let-2 mutants,
the intracellular stain generally appears as two spots on
opposite sides of the nucleus (Fig. 9 B and Figs. 5, 6, and
7). Apparently, the st545 and st540 mutations cause accu-
mulation of type IV collagen in a different intracellular
compartment within muscle cells than do the other muta-
tions.
Absence of Type IV Collagen Causes Body Wall
Muscle Disruption
emb-9 and let-2 mutant embryos were costained with an
antibody against myosin heavy chain B, which is expressed
in body wall muscle cells. The myosin staining served as a
Figure 5. Staining of putative emb-9 null mutants with type IV collagen antibodies. Embryos from unc-36 emb-9(g23cg45)/qC1 mothers
were stained with antisera against EMB-9 (A) or LET-2 (C), and body wall muscle myosin (B and D). Homozygous unc-36 emb-
9(g23cg45) embryos are indicated with arrows, and a heterozygous unc-36 emb-9(g23cg45)/qC1 embryo is marked with an arrowhead.
The heterozygous embryo stains with both the anti–EMB-9 (A, arrowhead) and antimyosin (B) antisera. The homozygous cg45 embryo
fails to stain with the anti–EMB-9 antiserum (A, arrow), but does stain with the antimyosin antiserum (B, arrow). Note the disruption of
the myosin staining pattern in the homozygous mutant. Two homozygous cg45 mutant embryos stain with anti–LET-2 antiserum (C, ar-
rows), but only show intracellular accumulation, no extracellular basement membrane stain. Both of these embryos stain with antimyo-
sin antiserum (D), but show a disrupted pattern.The Journal of Cell Biology, Volume 137, 1997 1192
control for permeability of embryos and permitted analy-
sis of the organization of body wall muscles. We had noted
previously that the body wall muscle quadrants were dis-
rupted in emb-9 and let-2 missense mutants. However, in
these mutants it is not clear if disruption is due to the ab-
sence of type IV collagen or the dominant interfering ef-
fects of abnormal type IV collagen. Analyses of the three
putative emb-9 null alleles indicate that they do cause dis-
ruption of the body wall muscle quadrants. In wild-type
animals, the four body wall muscle quadrants appear as
four stripes extending from head to tail of the animal (Fig.
10 A). In temperature-sensitive emb-9 or let-2 mutants at
Figure 6. Type IV collagen disruption in an emb-9 temperature-sensitive glycine substitution mutant. Staining of the temperature-sensi-
tive glycine substitution mutant emb-9(g23). Embryos grown at 258C (A and B), 208C (C and D), or 158C (E and F) were stained with
the anti–LET-2 (A, C, and E) and antimyosin antisera (B, D, and F). Staining with EMB-9 antisera gives a pattern identical to that seen
for LET-2. At 258C (A and B), type IV collagen appears as intense spots in body wall muscle cells, and there is little or no type IV in the
normal extracellular basement membrane locations. At 208C (C and D), intracellular accumulation of collagen IV is seen, though often
with reduced intensity, and weak staining of the basement membranes separating body wall muscle cells from the hypodermis is detected
(m). At 158C (E and F), intracellular accumulation of type IV collagen is greatly reduced, and strong stain of pharyngeal (p), intestinal,
and muscle (m) basement membranes is seen.
Figure 7. Type IV collagen distribution in a temperature-sensitive let-2 glycine substitution mutant. Staining of the temperature-sensi-
tive glycine substitution mutant let-2(b246). Embryos grown at 258C (A), 208C (B), or 158C (C) were stained with LET-2 antiserum. Stain-
ing with EMB-9 antiserum gives an identical pattern. At 258C, type IV collagen is seen as intense intracellular spots in body wall muscle
cells. Very faint staining of basement membranes is seen in some embryos. At 15 and 208C, type IV collagen is distributed in an essen-
tially wild-type pattern.Gupta et al. Caenorhabditis elegans Type IV Collagen Mutants 1193
high temperature, gaps in the body wall muscle quadrants
can first be seen at the 1 1/2-fold stage and become exten-
sive by the twofold stage (Fig. 10 B). In emb-9 null mutant
embryos, gaps also begin to appear at the 1 1/2-fold stage,
although they are generally less numerous and less severe
than in missense mutants. In two- to threefold emb-9 null
mutant embryos, numerous gaps in the body wall muscle
quadrants are apparent (Fig. 10 C). Since gaps in the body
wall muscle quadrants are seen in the emb-9 null mutants,
disruption of the body wall muscle quadrants can result
from the absence of type IV collagen in the basement
membrane. The first appearance of gaps in the body wall
muscle quadrants corresponds to the beginning of muscle
contractile activity, suggesting that the forces of contrac-
tion cause muscle cells to detach from the body wall.
Discussion
In wild-type and emb-9 or let-2 missense mutants, the
EMB-9 and LET-2 chains always colocalize. In emb-9 null
mutants, the LET-2 chain is retained intracellularly, indi-
cating that it requires EMB-9 to be assembled and/or se-
creted. All characterized type IV collagen molecules are
heterotrimers containing two a1-like and one a2-like chains
(Hudson et al., 1993). EMB-9 and LET-2 are a1 and
a2(IV)-like chains and are likely to be the only type IV
collagen chains in C. elegans (Guo and Kramer, 1989). If
EMB-9 and LET-2 assemble into a single collagen mole-
cule, then mutations in either would interfere with the
folding of the triple-stranded collagen molecule, resulting
in interference with the assembly and secretion of both
chains. All of these considerations suggest that they as-
semble into a single type IV collagen molecule containing
two EMB-9 and one LET-2 chains.
The mutations of the a1(IV) collagen gene emb-9 show
a range of phenotypic severities, similar to that found for
the a2(IV) gene let-2 (Sibley et al., 1994). Most mutations
are substitutions for glycine residues in the Gly-X-Y re-
peat domain of the molecule. It was noted that the pheno-
typic severities of glycine substitution mutations in let-2
are inversely correlated with the calculated helical stability
of type IV collagen at the position of the mutation (Sibley
Table II. Distribution of the LET-2 Type IV Collagen Chain in 
let-2 Mutants*
Strain
Percentage punctate
intracellular stain‡
Percentage pharyngeal
basement membrane stain§
15°C 20°C 25°C 15°C 20°C 25°C
N2 3 0 10 100 87 87
unc-3(e151) 0 0 0 100 100 100
let-2(g25) ND 15 73 ND 97 21
let-2(b246) 0 0 79 97 100 24
let-2(mn139) ND 57 85 ND 55 9
let-2(mn109) 48 45 93 100 68 2
let-2(g30) 0 100 94 91 24 1
let-2(mn129) ND 60 83 ND 83 33
*Embryos from homozygous mutant or wild-type (N2) mothers were stained with
LET-2 and UNC-54 antisera. Only embryos that showed UNC-54 stain were exam-
ined. At least 30 embryos were scored for each strain at each temperature.
‡The percentage of twofold stage or later embryos that showed strong intracellular
LET-2 stain in body wall muscle cells.
§The percentage of twofold stage or later embryos that showed strong LET-2 stain of
the pharyngeal basement membrane.
Figure 8. Type IV collagen
distribution in a non–temper-
ature-sensitive glycine substi-
tution mutant. emb-9(cg56)
embryos grown at 158C (A
and B) or 258C (C and D)
were stained with antisera
against LET-2 (A and C) and
body wall muscle myosin (B
and D). Strong type IV col-
lagen stain is seen within
body wall muscle cells, while
very weak stain is seen in the
basement membrane be-
neath the muscle cells. The
staining pattern is not af-
fected by temperature and
appears identical using
EMB-9 antisera.The Journal of Cell Biology, Volume 137, 1997 1194
et al., 1994). The most severe mutations are in regions of
low stability, and the mildest mutations are in regions of
high stability. This correlation is also apparent for the
emb-9 glycine substitution mutations. The mildest allele
(b117) is in a region of above average stability, while the
more severe alleles (g23, hc70, b189, cg56) are in regions
of below average stability. For both emb-9 and let-2, more
severe alleles are located in lower stability regions, and
milder alleles are in higher stability regions.
The phenotypes of most emb-9 and let-2 mutations are
temperature-sensitive. As the temperature is increased,
the percentage of arrested animals increases and arrest oc-
curs earlier in development. Staining of mutant animals
with type IV collagen antisera showed that as the tempera-
ture was increased, more of the mutant collagen was re-
tained within cells, and less was detected in basement
membranes. Thus, the more severe phenotype at higher
temperature likely results because less type IV collagen is
present in basement membranes. Mutant type IV collagen
that is able to assemble into the basement membrane pro-
vides function and results in a less severe phenotype. We
found no evidence for mutant type IV collagen that was
able to assemble into basement membranes but did not
provide function.
Assembly of collagen molecules requires registration of
three chains at or near the carboxyl terminus, nucleation
of the triple-helix, and propagation of the triple-helical
structure towards the amino end of the molecule. The col-
lagen triple helix is stabilized by hydrogen bonding and is
an inherently temperature-sensitive structure (Engel and
Prockop, 1991; Bachinger et al., 1993). Glycine residues
are required at every third position because they are the
only residue that can be accommodated in the center of
the triple helix without distortion of the structure and loss
Figure 9. Type IV collagen distribution in Class II emb-9 mutants. Staining of st540 (A) and cg56 (B) homozygous embryos with anti–
LET-2 antiserum. Type IV collagen accumulates in a perinuclear ring in st540 mutant embryos (A, arrows), while it primarily accumu-
lates in two spots on either side of the nucleus in cg56 mutant embryos (B, arrows). The same pattern is seen with EMB-9 and LET-2 an-
tisera. st545 shows the same pattern as st540, while all other emb-9 and let-2 mutants look like cg56.
Figure 10. Body wall muscle disruption in emb-9 mutants. Wild-type N2 (A), homozygous g23 (B), and homozygous cg46 (C) embryos
were grown at 258C and stained with antibody against body wall muscle myosin. In wild-type embryos, the muscle quadrants are contin-
uous from head to tail. Gaps are seen in the muscle quadrants of the mutant embryos (arrows).Gupta et al. Caenorhabditis elegans Type IV Collagen Mutants 1195
of stabilizing bonds. Glycine substitution mutations in the
Gly-X-Y repeat domain of collagen interrupt the folding
of the triple helix, requiring renucleation on the amino
side of the substitution for triple helix assembly to progress.
C. elegans type IV collagen glycine substitution muta-
tions can be viewed in terms of their effects on triple helix
stability. Substitutions in regions of low helical stability
cause more severe effects than those in high stability re-
gions. Introduction of a glycine substitution in an already
low stability region would produce such an unstable area
that renucleation of triple helix assembly might be very in-
efficient or impossible. Milder alleles, located in more stable
regions, would allow renucleation to occur more readily.
The temperature sensitivity of most glycine substitutions
could result because increased temperature would reduce
the stability of the entire triple-helical domain. The muta-
tions causing the most severe phenotypes are located in re-
gions of low triple-helical stability, and a small increase in
temperature would be sufficient to prevent assembly. The
milder mutations are located in regions with higher stabil-
ity, and larger increase in temperature would be required
to completely block assembly.
The three putative null mutations generated in this
study all have phenotypic characteristics distinct from
other  emb-9 mutations. While all other mutations in emb-9
and let-2, except cg56, cause arrest at approximately the
twofold stage of embryogenesis, the null mutants arrest
later, at the three- to fourfold stage. Since null mutant ani-
mals are capable of developing further than the missense
mutants, the missense protein must interfere with the
function of some other molecule(s). The missense chains
act in a dominant negative fashion, interfering not only
with the wild-type type IV collagen, but also with some
other molecule(s). This interference could occur intracel-
lularly, in the RER or Golgi network, and/or extracellu-
larly, in basement membranes.
As shown here for emb-9 and previously for let-2 (Sibley
et al., 1994), the dominant lethality of temperature-sensi-
tive glycine substitution mutations increases with increas-
ing temperature. Antibody staining shows that as the tem-
perature increases, less type IV collagen is secreted. At the
highest temperature tested, no type IV is detected in base-
ment membranes. Since the dominance of these mutations
becomes more severe as more type IV collagen is retained
intracellularly and less is secreted, it is likely that domi-
nant interference is occurring intracellularly, not in the
basement membrane. Accumulation of large amounts of
the abnormal collagen within cells could interfere with the
synthesis, processing, and/or secretion of other proteins,
thereby resulting in a more severe phenotype than results
from simple loss of type IV collagen.
In emb-9 null mutants, the LET-2 chain accumulates
intracellularly but does not cause detectable dominant
effects. Since LET-2 is the a2-like chain, it is not likely to
undergo any trimeric assembly in the absence of EMB-9.
In contrast, when there is a glycine substitution in either
EMB-9 or LET-2, trimeric assembly is likely to initiate
normally but be blocked when it reaches the site of the
substitution. Intracellular accumulation of these partially as-
sembled trimeric molecules appears to be more detrimen-
tal than accumulation of individual, unassembled LET-2
chains.
The dominant interference caused by mutations in type
IV collagen and fibrillar collagens may result from differ-
ent mechanisms. Glycine substitutions in mammalian fib-
rillar type I collagen inhibit collagen triple helix assembly
and result in intracellular degradation of much of the mu-
tant and normal collagen chains (Prockop et al., 1989; En-
gel and Prockop, 1991). Secretion of small amounts of gly-
cine substitution containing type I collagen into the matrix
can dominantly disrupt collagen fiber formation. Glycine
substitutions can cause bulges or kinks in the collagen
molecule (Prockop et al., 1989; Engel and Prockop, 1991).
Since fibrillar collagens assemble into highly ordered,
closely packed fibers, the presence of an abnormal col-
lagen molecule distorts the packing of other molecules in
the fiber. In contrast, type IV collagen normally contains
20 or more interruptions of its Gly-X-Y domain and forms
a looser, less ordered network (Yurchenco and Ruben,
1987). Incorporation of a type IV collagen molecule con-
taining a glycine substitution is not likely to greatly disrupt
the type IV network. Collagen molecules containing gly-
cine substitutions are likely to be much less disruptive to
the type IV network than to the highly ordered fibers
formed by fibrillar collagens. This conclusion is consistent
with our evidence that the dominance of the C. elegans
type IV collagen mutations is not an extracellular effect,
but occurs intracellularly.
The effects on type IV collagen distribution in animals
with mutations in type IV collagen genes appear some-
what different in mammals and C. elegans. In the kidneys
of humans, mice, or dogs with mutations in the a3–a5(IV)
collagen genes, type IV collagen is not detected in base-
ment membranes or within cells (Gubler et al., 1995; Peis-
sel et al., 1995; Cosgrove et al., 1996; Miner and Sanes,
1996; Thorner et al., 1996). In C. elegans mutants, type IV
collagen can be reduced or absent from basement mem-
branes but is correspondingly seen to accumulate within
the cells that synthesize it. This difference could result
from a higher synthesis rate and/or a lower degradation
rate for type IV collagen in C. elegans. The C. elegans type
IV collagen mutants arrest during embryogenesis, when
there is high transcriptional activity of the type IV col-
lagen genes (Graham et al., 1997), and the mutant animals
are fixed and stained within a few hours after the time of
their arrest. There may not be enough intracellular degra-
dative activity in C. elegans to remove the accumulated
type IV collagen during this short period.
In  emb-9 null mutants, we detected disruption of the
body wall muscles beginning at the 1 1/2-fold stage, when
contractions first begin. The disruption worsens as muscle
contractions become more vigorous, and muscle cells ap-
pear to pull away from the hypodermis. It has been shown
that body wall muscle function is required for elongation
of the C. elegans embryo beyond the two-fold stage (Wa-
terston, 1989; Barstead and Waterston, 1991; Williams and
Waterston, 1994). The disruption of the body wall muscles
that we see is sufficient to explain why the embryos arrest.
At the time of arrest, the organization of other tissues,
such as the pharynx and intestine, appears relatively nor-
mal. The type IV collagen that assembles into the base-
ment membrane that separates body wall muscles from
the hypodermis is critical for maintaining attachment of
the body wall muscles during the force of contraction.The Journal of Cell Biology, Volume 137, 1997 1196
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